<code id='72C71F1ADB'></code><style id='72C71F1ADB'></style>
    • <acronym id='72C71F1ADB'></acronym>
      <center id='72C71F1ADB'><center id='72C71F1ADB'><tfoot id='72C71F1ADB'></tfoot></center><abbr id='72C71F1ADB'><dir id='72C71F1ADB'><tfoot id='72C71F1ADB'></tfoot><noframes id='72C71F1ADB'>

    • <optgroup id='72C71F1ADB'><strike id='72C71F1ADB'><sup id='72C71F1ADB'></sup></strike><code id='72C71F1ADB'></code></optgroup>
        1. <b id='72C71F1ADB'><label id='72C71F1ADB'><select id='72C71F1ADB'><dt id='72C71F1ADB'><span id='72C71F1ADB'></span></dt></select></label></b><u id='72C71F1ADB'></u>
          <i id='72C71F1ADB'><strike id='72C71F1ADB'><tt id='72C71F1ADB'><pre id='72C71F1ADB'></pre></tt></strike></i>

          Home / fashion / explore

          explore


          explore

          author:fashion    Page View:88
          Adam's take main illustration
          Molly Ferguson/STAT

          Biotech is awash in PIPEs.

          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

          advertisement

          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In